These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35747110)

  • 1. Ivermectin-Induced Acute Psychosis in Patients Infected With COVID-19 Pneumonia.
    Goyal L; Pandit R; Pandit T; Ajmera K; Lusins JO; Islam S
    Cureus; 2022 Jun; 14(6):e26141. PubMed ID: 35747110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the ICF in assessing the effectiveness of magnetotherapy in patients with viral pneumonia associated with COVID-19].
    Bodrova RA; Zakamyrdina AD; Fakhrutdinov IA; Dilyan AM; Mavzyutova RR; Kuchumova TV; Yunusova ER
    Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(5):24-31. PubMed ID: 34719905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A child infected with severe acute respiratory syndrome coronavirus 2 presenting with diarrhea without fever and cough: A case report.
    Liu Q; Zhang Y; Long Y
    Medicine (Baltimore); 2020 Aug; 99(33):e21427. PubMed ID: 32871990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.
    Li J; Chen Z; Nie Y; Ma Y; Guo Q; Dai X
    J Med Internet Res; 2020 Jun; 22(6):e19636. PubMed ID: 32544071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of Low-Frequency Magnetic Therapy in Patients with COVID-19 Pneumonia].
    Bodrova RA; Kuchumova TV; Zakamyrdina AD; Yunusova ER; Fadeev GY
    Vopr Kurortol Fizioter Lech Fiz Kult; 2020; 97(6):11-16. PubMed ID: 33307658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Case of COVID-19 Presenting as Acute Psychosis.
    Lanier CG; Lewis SA; Patel PD; Ahmed AM; Lewis PO
    J Pharm Pract; 2022 Jun; 35(3):488-491. PubMed ID: 33280502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q Fever: an old but still a poorly understood disease.
    Honarmand H
    Interdiscip Perspect Infect Dis; 2012; 2012():131932. PubMed ID: 23213331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of COVID-19 Outpatients: A Cross-Sectional Study.
    Niaee MS; Zolghadr L; Hosseinkhani Z; Namdar P; Allami A; Amini F; Varnaseri M; Pourdast A; Gheibi N
    Iran J Sci Technol Trans A Sci; 2022; 46(5):1369-1375. PubMed ID: 36187299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia.
    Gaba WH; Ahmed D; Al Nuaimi RK; Dhanhani AA; Eatamadi H
    Am J Case Rep; 2020 Oct; 21():e927691. PubMed ID: 33116072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.